• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测对心血管代谢发病率和死亡率的不良生活方式风险因素的敏感性。

Predicting Sensitivity to Adverse Lifestyle Risk Factors for Cardiometabolic Morbidity and Mortality.

机构信息

Department of Clinical Sciences Malmö, Lund University Diabetes Centre, Lund University, 21428 Malmö, Sweden.

Department of Public Health and Clinical Medicine, Umeå University, 90187 Umeå, Sweden.

出版信息

Nutrients. 2022 Aug 1;14(15):3171. doi: 10.3390/nu14153171.

DOI:10.3390/nu14153171
PMID:35956347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9370461/
Abstract

People appear to vary in their susceptibility to lifestyle risk factors for cardiometabolic disease; determining who is most sensitive may help optimize the timing, design, and delivery of preventative interventions. We aimed to ascertain a person's degree of resilience or sensitivity to adverse lifestyle exposures and determine whether these classifications help predict cardiometabolic disease later in life; we pooled data from two population-based Swedish prospective cohort studies (n = 53,507), and we contrasted an individual's cardiometabolic biomarker profile with the profile predicted for them given their lifestyle exposure characteristics using a quantile random forest approach. People who were classed as 'sensitive' to hypertension- and dyslipidemia-related lifestyle exposures were at higher risk of developing cardiovascular disease (CVD, hazards ratio 1.6 (95% CI: 1.3, 1.91)), compared with the general population. No differences were observed for type 2 diabetes (T2D) risk. Here, we report a novel approach to identify individuals who are especially sensitive to adverse lifestyle exposures and who are at higher risk of subsequent cardiovascular events. Early preventive interventions may be needed in this subgroup.

摘要

人们似乎对心血管代谢疾病的生活方式风险因素有不同的易感性;确定谁最敏感可能有助于优化预防干预的时机、设计和实施。我们旨在确定一个人对不良生活方式暴露的适应能力或敏感性程度,并确定这些分类是否有助于预测日后的心血管代谢疾病;我们对两项基于人群的瑞典前瞻性队列研究的数据进行了汇总(n=53507),并使用分位数随机森林方法对比了个体的心血管代谢生物标志物特征与其根据生活方式暴露特征预测的特征。与一般人群相比,被归类为对高血压和血脂异常相关生活方式暴露“敏感”的人群患心血管疾病(CVD,风险比 1.6(95%CI:1.3,1.91))的风险更高。对于 2 型糖尿病(T2D)风险则未观察到差异。在这里,我们报告了一种识别对不良生活方式暴露特别敏感且随后发生心血管事件风险较高的个体的新方法。在这个亚组中可能需要早期预防干预。

相似文献

1
Predicting Sensitivity to Adverse Lifestyle Risk Factors for Cardiometabolic Morbidity and Mortality.预测对心血管代谢发病率和死亡率的不良生活方式风险因素的敏感性。
Nutrients. 2022 Aug 1;14(15):3171. doi: 10.3390/nu14153171.
2
[Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].[心血管风险与心脏代谢风险:一项流行病学评估]
G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):6S-17S.
3
Development of a cost-effective CVD prediction model using lifestyle factors. A cohort study in Pakistan.利用生活方式因素开发具有成本效益的心血管疾病预测模型:巴基斯坦的一项队列研究。
Afr Health Sci. 2020 Jun;20(2):849-859. doi: 10.4314/ahs.v20i2.39.
4
Cardiometabolic health risks, lifestyle behaviours and quality of life in people diagnosed with early psychosis - A cross-sectional study.心血管代谢健康风险、生活方式行为与早期精神病诊断患者的生活质量 - 一项横断面研究。
J Psychiatr Ment Health Nurs. 2022 Aug;29(4):578-591. doi: 10.1111/jpm.12809. Epub 2021 Dec 8.
5
Cardiometabolic risk estimation using exposome data and machine learning.使用暴露组数据和机器学习进行心脏代谢风险评估。
Int J Med Inform. 2023 Nov;179:105209. doi: 10.1016/j.ijmedinf.2023.105209. Epub 2023 Sep 12.
6
Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis.多囊卵巢综合征女性的长期心脏代谢疾病风险:系统评价和荟萃分析。
Hum Reprod Update. 2020 Nov 1;26(6):942-960. doi: 10.1093/humupd/dmaa029.
7
A meta-review of lifestyle interventions for cardiovascular risk factors in the general medical population: lessons for individuals with serious mental illness.针对普通医疗人群心血管危险因素的生活方式干预的元综述:对严重精神疾病患者的启示
J Clin Psychiatry. 2015 Apr;76(4):e477-86. doi: 10.4088/JCP.13r08657.
8
Association of body mass index and its long-term changes with cardiometabolic diseases: A nationwide twin study.体重指数及其长期变化与心血管代谢疾病的关联:一项全国性双胞胎研究。
Clin Nutr. 2021 Nov;40(11):5467-5474. doi: 10.1016/j.clnu.2021.09.030. Epub 2021 Sep 29.
9
Cardiometabolic risk: New chronic care models.心脏代谢风险:新的慢性病护理模式。
JPEN J Parenter Enteral Nutr. 2021 Nov;45(S2):85-92. doi: 10.1002/jpen.2264.
10
Preventing Diabetes and Atherosclerosis in the Cardiometabolic Syndrome.预防心脏代谢综合征中的糖尿病和动脉粥样硬化。
Curr Atheroscler Rep. 2021 Mar 9;23(4):16. doi: 10.1007/s11883-021-00913-8.

引用本文的文献

1
Complex interaction of waist circumference, cardiometabolic markers, and sex on elderly mortality: a cohort study of 0.4 million UK adults.腰围、心脏代谢标志物和性别对老年人死亡率的复杂相互作用:一项对40万英国成年人的队列研究。
NPJ Metab Health Dis. 2025 Jul 2;3(1):31. doi: 10.1038/s44324-025-00075-0.
2
Subclassification of obesity for precision prediction of cardiometabolic diseases.肥胖的亚分类用于心血管代谢疾病的精准预测。
Nat Med. 2025 Feb;31(2):534-543. doi: 10.1038/s41591-024-03299-7. Epub 2024 Oct 24.

本文引用的文献

1
Exposome-wide ranking of modifiable risk factors for cardiometabolic disease traits.暴露组学全基因组范围内可改变的心血管代谢疾病风险因素的排名。
Sci Rep. 2022 Mar 8;12(1):4088. doi: 10.1038/s41598-022-08050-1.
2
Correlation of physical and cognitive impairment in diabetic and hypertensive frail older adults.糖尿病和高血压衰弱老年人身体和认知功能障碍的相关性。
Cardiovasc Diabetol. 2022 Jan 19;21(1):10. doi: 10.1186/s12933-021-01442-z.
3
SGLT2 inhibitors: the statins of the 21st century.钠-葡萄糖协同转运蛋白2抑制剂:21世纪的他汀类药物。
Eur Heart J. 2022 Mar 14;43(11):1029-1030. doi: 10.1093/eurheartj/ehab765.
4
Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review.针对高危个体和整个人群的糖尿病预防干预措施的成本效益:系统评价。
Diabetes Care. 2020 Jul;43(7):1593-1616. doi: 10.2337/dci20-0018.
5
15. Diabetes Care in the Hospital: .医院中的糖尿病护理: 。
Diabetes Care. 2021 Jan;44(Suppl 1):S211-S220. doi: 10.2337/dc21-S015.
6
Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).糖尿病精准医学:美国糖尿病协会(ADA)和欧洲糖尿病研究协会(EASD)的共识报告。
Diabetologia. 2020 Sep;63(9):1671-1693. doi: 10.1007/s00125-020-05181-w.
7
Human postprandial responses to food and potential for precision nutrition.人类对食物的餐后反应和精准营养的潜力。
Nat Med. 2020 Jun;26(6):964-973. doi: 10.1038/s41591-020-0934-0. Epub 2020 Jun 11.
8
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019 ACC/AHA 心血管疾病一级预防指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南工作组的报告。
J Am Coll Cardiol. 2019 Sep 10;74(10):1376-1414. doi: 10.1016/j.jacc.2019.03.009. Epub 2019 Mar 17.
9
Demonstrating Heterogeneity of Treatment Effects Among Patients: An Overlooked but Important Step Toward Precision Medicine.展示患者间治疗效果的异质性:迈向精准医学的被忽视但重要的一步。
Clin Pharmacol Ther. 2019 Jul;106(1):204-210. doi: 10.1002/cpt.1372. Epub 2019 Mar 12.
10
The Role of Nutrients in Reducing the Risk for Noncommunicable Diseases during Aging.营养素在降低衰老相关非传染性疾病风险中的作用。
Nutrients. 2019 Jan 4;11(1):85. doi: 10.3390/nu11010085.